Calcineurin (CN) inhibitors are effective clinical immunosuppressants but leave patients vulnerable to potentially fatal fungal infections. This study tested the hypothesis that CN inhibition interferes with antifungal immune defenses mediated by monocytes. We showed that NFAT is expressed by human monocytes, and is activated by exposure to fungal ligands. We confirmed that NFAT translocation potently activated target gene transcription using a human monocytic reporter cell line. Inhibition of CN-NFAT by cyclosporine A significantly reduced monocyte production of TNF-α, IL-10, and MCP-1 proteins in response to pattern recognition receptor ligands as well as to Aspergillus fumigatus conidia. Moreover, we revealed that human monocytes express the antifungal protein pentraxin-3 under control of NFAT. In conclusion, clinical CN inhibitors have the potential to interfere with the novel NFAT-dependent pentraxin-3 pathway as well as antifungal cytokine production in human monocytes, thereby impeding monocyte-mediated defenses against fungal infection in immune-suppressed patients.

Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Experimental Medicine University of Perugia Perugia Italy

International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic

See more in PubMed

Rush D. The impact of calcineurin inhibitors on graft survival. Transplant Rev (Orlando). 2013;27:93‐95. PubMed

Vaeth M, Bauerlein CA, Pusch T, et al. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity. PNAS. 2015;112:1125‐1130. PubMed PMC

Nasu R, Nannya Y, Shinohara A, Ichikawa M, Kurokawa M. Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard‐risk hematological diseases. Ann Hematol. 2014;93:1215‐1223. PubMed

Bendickova K, Tidu F, Fric J. Calcineurin‐NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy. EMBO Mol Med. 2017;9:990‐999. PubMed PMC

Fishman JA. Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl. 2011;17(Suppl 3):S34‐7. PubMed

Steinmann J, Hamprecht A, Vehreschild MJ, et al. Emergence of azole‐resistant invasive aspergillosis in HSCT recipients in Germany. J Antimicrob Chemother. 2015;70:1522‐1526. PubMed

Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010;50:1559‐1567. PubMed PMC

Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50:1101‐1111. PubMed

Fric J, Zelante T, Wong AY, Mertes A, Yu HB, Ricciardi‐Castagnoli P. NFAT control of innate immunity. Blood. 2012;120:1380‐1389. PubMed

Granucci F, Vizzardelli C, Pavelka N, et al. Inducible IL‐2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol. 2001;2:882‐888. PubMed

Granucci F, Feau S, Angeli V, Trottein F, Ricciardi‐Castagnoli P. Early IL‐2 production by mouse dendritic cells is the result of microbial‐induced priming. J Immunol. 2003;170:5075‐5081. PubMed

Zelante T, Wong AY, Ping TJ, et al. CD103(+) dendritic cells control Th17 cell function in the lung. Cell Rep. 2015;12:1789‐1801. PubMed

Mencarelli A, Khameneh HJ, Fric J, et al. Calcineurin‐mediated IL‐2 production by CD11c(high)MHCII(+) myeloid cells is crucial for intestinal immune homeostasis. Nat Commun. 2018;9:1102. PubMed PMC

Yu HB, Yurieva M, Balachander A, et al. NFATc2 mediates epigenetic modification of dendritic cell cytokine and chemokine responses to dectin‐1 stimulation. Nucleic Acids Res. 2015;43:836‐847. PubMed PMC

Jennings C, Kusler B, Jones PP. Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS‐induced toxicity in vivo. Innate Immun. 2009;15:109‐120. PubMed PMC

Elloumi HZ, Maharshak N, Rao KN, et al. A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis. PLoS One. 2012;7:e34172. PubMed PMC

Herbst S, Shah A, Carby M, et al. A new and clinically relevant murine model of solid‐organ transplant aspergillosis. Dis Model Mech. 2013;6:643‐651. PubMed PMC

Shah A, Kannambath S, Herbst S, et al. Calcineurin orchestrates lateral transfer of aspergillus fumigatus during macrophage cell death. Am J Respir Crit Care Med. 2016;194:1127‐1139. PubMed PMC

Bercusson A, Colley T, Shah A, Warris A, Armstrong‐James D. Ibrutinib blocks Btk‐dependent NF‐kB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis. Blood. 2018;132:1985‐1988. PubMed PMC

Zanoni I, Ostuni R, Capuano G, et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature. 2009;460:264‐268. PubMed

Herbst S, Shah A, Mazon Moya M, et al. Phagocytosis‐dependent activation of a TLR9‐BTK‐calcineurin‐NFAT pathway co‐ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240‐258. PubMed PMC

Goodridge HS, Simmons RM, Underhill DM. Dectin‐1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J Immunol. 2007;178:3107‐3115. PubMed

Cunha C, Di Ianni M, Bozza S, et al. Dectin‐1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient‐ and donor‐dependent mechanisms of antifungal immunity. Blood. 2010;116:5394‐5402. PubMed

Dambuza IM, Brown GD. C‐type lectins in immunity: recent developments. Curr Opin Immunol. 2015;32:21‐27. PubMed PMC

Greenblatt MB, Aliprantis A, Hu B, Glimcher LH. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med. 2010. PubMed PMC

Zelante T, Wong AY, Mencarelli A, et al. Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin‐3 and increased susceptibility to aspergillosis. Mucosal Immunol. 2017;10:470‐480. PubMed

Garlanda C, Hirsch E, Bozza S, et al. Non‐redundant role of the long pentraxin PTX3 in anti‐fungal innate immune response. Nature. 2002;420:182‐186. PubMed

Cunha C, Aversa F, Lacerda JF, et al. Genetic PTX3 deficiency and aspergillosis in stem‐cell transplantation. N Engl J Med. 2014;370:421‐432. PubMed

Imamura M, Kawasaki T, Savchenko AS, et al. Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte‐derived macrophages. Cell Immunol. 2007;248:86‐94. PubMed

Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med. 2007;204:793‐804. PubMed PMC

Moalli F, Doni A, Deban L, et al. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood. 2010;116:5170‐5180. PubMed

Basile A, Sica A, d'Aniello E, et al. Characterization of the promoter for the human long pentraxin PTX3. Role of NF‐kappaB in tumor necrosis factor‐alpha and interleukin‐1beta regulation. J Biol Chem. 1997;272:8172‐8178. PubMed

Schindelin J, Arganda‐Carreras I, Frise E, et al. Fiji: an open‐source platform for biological‐image analysis. Nat Methods. 2012;9:676‐682. PubMed PMC

Ziegler‐Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116:e74‐80. PubMed

Davis S, Meltzer PS. GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor. Bioinformatics. 2007;23:1846‐1847. PubMed

Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA‐sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. PubMed PMC

Frazer KA, Pachter L, Poliakov A, Rubin EM, Dubchak I. VISTA: computational tools for comparative genomics. Nucleic Acids Res. 2004;32:W273‐9. PubMed PMC

Lee C, Huang CH. LASAGNA‐Search: an integrated web tool for transcription factor binding site search and visualization. Bio Techniques. 2013;54:141‐153. PubMed

Khan A, Fornes O, Stigliani A, et al. JASPAR 2018: update of the open‐access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 2018;46:D260‐D266. PubMed PMC

Heimbeck I, Hofer TP, Eder C, et al. Standardized single‐platform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females. Cytometry A. 2010;77:823‐830. PubMed

Breviario F, d'Aniello EM, Golay J, et al. Interleukin‐1‐inducible genes in endothelial cells. Cloning of a new gene related to C‐reactive protein and serum amyloid P component. J Biol Chem. 1992;267:22190‐22197. PubMed

Altmeyer A, Klampfer L, Goodman AR, Vilcek J. Promoter structure and transcriptional activation of the murine TSG‐14 gene encoding a tumor necrosis factor/interleukin‐1‐inducible pentraxin protein. J Biol Chem. 1995;270:25584‐25590. PubMed

Imbert S, Bresler P, Boissonnas A, et al. Calcineurin inhibitors impair neutrophil activity against Aspergillus fumigatus in allogeneic hematopoietic stem cell transplant recipients. J Allergy Clin Immunol. 2016;138:860‐868. PubMed

Tourneur E, Ben Mkaddem S, Chassin C, et al. Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)‐mediated innate antibacterial renal defenses in mice and human transplant recipients. PLoS Pathog. 2013;9:e1003152. PubMed PMC

Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte‐mediated defense against microbial pathogens. Annu Rev Immunol. 2008;26:421‐452. PubMed PMC

Ketter P, Yu JJ, Cap AP, Forsthuber T, Arulanandam B. Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis. Expert Rev Clin Immunol. 2016;12:501‐507. PubMed

Daigo K, Nakakido M, Ohashi R, et al. Protective effect of the long pentraxin PTX3 against histone‐mediated endothelial cell cytotoxicity in sepsis. Sci Signal. 2014;7:ra88. PubMed

Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non‐survivor septic shock patients: a preliminary study. Immunol Lett. 2006;106:63‐71. PubMed

Tang BM, Huang SJ, McLean AS. Genome‐wide transcription profiling of human sepsis: a systematic review. Crit Care. 2010;14:R237. PubMed PMC

Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med. 2009;15:496‐497. PubMed PMC

Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594‐2605. PubMed PMC

Ziegler‐Heitbrock HW, Strobel M, Kieper D, et al. Differential expression of cytokines in human blood monocyte subpopulations. Blood. 1992;79:503‐511. PubMed

Gaziano R, Bozza S, Bellocchio S, et al. Anti‐Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother. 2004;48:4414‐4421. PubMed PMC

Caironi P, Masson S, Mauri T, et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. Eur J Clin Invest. 2017;47:73‐83. PubMed PMC

Jie H, Li Y, Pu X, Ye J. Pentraxin 3, a predicator for 28‐day mortality in patients with septic shock. Am J Med Sci. 2017;353:242‐246. PubMed

Kurt OK, Tosun M, Kurt EB, Talay F. Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease. Inflammation. 2015;38:89‐93. PubMed

Pang Z, Junkins RD, MacNeil AJ, et al. The calcineurin‐NFAT axis contributes to host defense during Pseudomonas aeruginosa lung infection. J Leukoc Biol. 2017;102:1461‐1469. PubMed

Junkins RD, MacNeil AJ, Wu Z, McCormick C, Lin TJ. Regulator of calcineurin 1 suppresses inflammation during respiratory tract infections. J Immunol. 2013;190:5178‐5186. PubMed

Frantz B, Nordby EC, Bren G, et al. Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B. EMBO J. 1994;13:861‐870. PubMed PMC

Immunosuppression Affects Neutrophil Functions: Does Calcineurin-NFAT Signaling Matter?

NFAT signaling in human mesenchymal stromal cells affects extracellular matrix remodeling and antifungal immune responses

Roles of IL-2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy